Invention Grant
- Patent Title: Methods and compositions for the treatment of diverticulosis
-
Application No.: US16501039Application Date: 2019-02-11
-
Publication No.: US11304918B2Publication Date: 2022-04-19
- Inventor: Yutaka Niihara
- Applicant: Emmaus Medical, Inc.
- Applicant Address: US CA Torrance
- Assignee: Emmaus Medical, Inc.
- Current Assignee: Emmaus Medical, Inc.
- Current Assignee Address: US CA Torrance
- Agency: McKinney Law Group APC
- Agent Jeffrey A. McKinney
- Main IPC: A61K31/198
- IPC: A61K31/198 ; A61K31/717 ; A61K31/721 ; A61K36/68 ; A23L33/24 ; A23L33/10 ; A23L33/00 ; A23L33/175 ; A23L33/105

Abstract:
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
Public/Granted literature
- US20190201361A1 Methods and compositions for the treatment of diverticulosis Public/Granted day:2019-07-04
Information query
IPC分类: